155 related articles for article (PubMed ID: 27019866)
1. Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges.
O'Bryant SE; Lista S; Rissman RA; Edwards M; Zhang F; Hall J; Zetterberg H; Lovestone S; Gupta V; Graff-Radford N; Martins R; Jeromin A; Waring S; Oh E; Kling M; Baker LD; Hampel H
Alzheimers Dement (Amst); 2016; 3():27-34. PubMed ID: 27019866
[TBL] [Abstract][Full Text] [Related]
2. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
[TBL] [Abstract][Full Text] [Related]
3. Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection.
Leligdowicz A; Conroy AL; Hawkes M; Zhong K; Lebovic G; Matthay MA; Kain KC
PLoS One; 2017; 12(4):e0175130. PubMed ID: 28419100
[TBL] [Abstract][Full Text] [Related]
4. Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.
Villarreal AE; O'Bryant SE; Edwards M; Grajales S; Britton GB;
Neurodegener Dis Manag; 2016 Jun; 6(3):203-13. PubMed ID: 27229914
[TBL] [Abstract][Full Text] [Related]
5. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis.
Malekzadeh A; Twaalfhoven H; Wijnstok NJ; Killestein J; Blankenstein MA; Teunissen CE
Cytokine; 2017 Mar; 91():145-152. PubMed ID: 28082233
[TBL] [Abstract][Full Text] [Related]
6. IL-7 and Depression: The importance of gender and blood fraction.
Hall JR; Wiechmann A; Edwards M; Johnson LA; O'Bryant SE
Behav Brain Res; 2016 Dec; 315():147-9. PubMed ID: 27555535
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia.
Le Bastard N; Coart E; Vanderstichele H; Vanmechelen E; Martin JJ; Engelborghs S
J Alzheimers Dis; 2013; 33(1):117-31. PubMed ID: 22936010
[TBL] [Abstract][Full Text] [Related]
8. Peripheral cytokines, C-X-C motif ligand10 and interleukin-13, are associated with Malaysian Alzheimer's disease.
Mohd Hasni DS; Lim SM; Chin AV; Tan MP; Poi PJH; Kamaruzzaman SB; Majeed ABA; Ramasamy K
Geriatr Gerontol Int; 2017 May; 17(5):839-846. PubMed ID: 27215446
[TBL] [Abstract][Full Text] [Related]
9. How to: Measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays.
Belzeaux R; Lefebvre MN; Lazzari A; Le Carpentier T; Consoloni JL; Zendjidjian X; Abbar M; Courtet P; Naudin J; Boucraut J; Gressens P; Glaichenhaus N; Ibrahim EC
Psychoneuroendocrinology; 2017 Jan; 75():72-82. PubMed ID: 27810706
[TBL] [Abstract][Full Text] [Related]
10. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S
Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
[TBL] [Abstract][Full Text] [Related]
12. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
14. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
[TBL] [Abstract][Full Text] [Related]
15. Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese.
Cheng Z; Yin J; Yuan H; Jin C; Zhang F; Wang Z; Liu X; Wu Y; Wang T; Xiao S
Front Aging Neurosci; 2018; 10():414. PubMed ID: 30618720
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.
Heywood WE; Galimberti D; Bliss E; Sirka E; Paterson RW; Magdalinou NK; Carecchio M; Reid E; Heslegrave A; Fenoglio C; Scarpini E; Schott JM; Fox NC; Hardy J; Bhatia K; Heales S; Sebire NJ; Zetterberg H; Mills K
Mol Neurodegener; 2015 Dec; 10():64. PubMed ID: 26627638
[TBL] [Abstract][Full Text] [Related]
17. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
[TBL] [Abstract][Full Text] [Related]
18. Comparison of multiplexed protein analysis platforms for the detection of biomarkers in the nasal epithelial lining fluid of healthy subjects.
Zetlen HL; Cao KT; Schichlein KD; Knight N; Maecker HT; Nadeau KC; Rebuli ME; Rice MB
J Immunol Methods; 2023 Jun; 517():113473. PubMed ID: 37059295
[TBL] [Abstract][Full Text] [Related]
19. The effect of assay type and sample matrix on detected cytokine concentrations in human blood serum and nasal lavage fluid.
Huttunen K; Tiihonen K; Roponen M; Heederik D; Zock JP; Täubel M; Hyvärinen A; Hirvonen MR
J Pharm Biomed Anal; 2014 Aug; 96():151-5. PubMed ID: 24742773
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.
Pavkovic M; Riefke B; Gutberlet K; Raschke M; Ellinger-Ziegelbauer H
J Pharmacol Toxicol Methods; 2014; 69(2):196-204. PubMed ID: 24333954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
